371 related articles for article (PubMed ID: 19204159)
21. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G
Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585
[TBL] [Abstract][Full Text] [Related]
22. HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data.
Watanabe M; Nakamura Y; Sato S; Niino M; Fukaura H; Tanaka M; Ochi H; Kanda T; Takeshita Y; Yokota T; Nishida Y; Matsui M; Nagayama S; Kusunoki S; Miyamoto K; Mizuno M; Kawachi I; Saji E; Ohashi T; Shimohama S; Hisahara S; Nishiyama K; Iizuka T; Nakatsuji Y; Okuno T; Ochi K; Suzumura A; Yamamoto K; Kawano Y; Tsuji S; Hirata M; Sakate R; Kimura T; Shimizu Y; Nagaishi A; Okada K; Hayashi F; Sakoda A; Masaki K; Shinoda K; Isobe N; Matsushita T; Kira JI
Sci Rep; 2021 Jan; 11(1):607. PubMed ID: 33436735
[TBL] [Abstract][Full Text] [Related]
23. HLA-DR and -DQ associations with multiple sclerosis in Turkey.
Saruhan-Direskeneli G; Esin S; Baykan-Kurt B; Ornek I; Vaughan R; Eraksoy M
Hum Immunol; 1997 Jun; 55(1):59-65. PubMed ID: 9328791
[TBL] [Abstract][Full Text] [Related]
24. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
[TBL] [Abstract][Full Text] [Related]
25. Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.
Brill L; Mandel M; Karussis D; Petrou P; Miller K; Ben-Hur T; Karni A; Paltiel O; Israel S; Vaknin-Dembinsky A
J Neuroimmunol; 2016 Apr; 293():65-70. PubMed ID: 27049564
[TBL] [Abstract][Full Text] [Related]
26. Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome.
Debiec H; Dossier C; Letouzé E; Gillies CE; Vivarelli M; Putler RK; Ars E; Jacqz-Aigrain E; Elie V; Colucci M; Debette S; Amouyel P; Elalaoui SC; Sefiani A; Dubois V; Simon T; Kretzler M; Ballarin J; Emma F; Sampson MG; Deschênes G; Ronco P
J Am Soc Nephrol; 2018 Jul; 29(7):2000-2013. PubMed ID: 29903748
[No Abstract] [Full Text] [Related]
27. HLA-DRB1, -DQA1, -DQB1, -DPA1 and -DPB1 genes in Japanese multiple sclerosis patients.
Spurkland A; Tabira T; Rønningen KS; Vandvik B; Thorsby E; Vartdal F
Tissue Antigens; 1991 Apr; 37(4):171-3. PubMed ID: 1926126
[TBL] [Abstract][Full Text] [Related]
28. HLA-DRB1, DQA1 and DQB1 DNA polymorphisms in healthy Algerian and genetic relationships with other populations.
Djoulah S; Sanchez-Mazas A; Khalil I; Benhamamouch S; Degos L; Deschamps I; Hors J
Tissue Antigens; 1994 Feb; 43(2):102-9. PubMed ID: 8016836
[TBL] [Abstract][Full Text] [Related]
29. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
30. Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations.
Alcina A; Abad-Grau Mdel M; Fedetz M; Izquierdo G; Lucas M; Fernández O; Ndagire D; Catalá-Rabasa A; Ruiz A; Gayán J; Delgado C; Arnal C; Matesanz F
PLoS One; 2012; 7(1):e29819. PubMed ID: 22253788
[TBL] [Abstract][Full Text] [Related]
31. The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis.
Kollaee A; Ghaffarpor M; Ghlichnia HA; Ghaffari SH; Zamani M
Int J Immunogenet; 2012 Oct; 39(5):414-22. PubMed ID: 22404765
[TBL] [Abstract][Full Text] [Related]
32. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease.
Koeleman BP; Lie BA; Undlien DE; Dudbridge F; Thorsby E; de Vries RR; Cucca F; Roep BO; Giphart MJ; Todd JA
Genes Immun; 2004 Aug; 5(5):381-8. PubMed ID: 15164102
[TBL] [Abstract][Full Text] [Related]
33. HLA-DRB1, -DQA1, -DQB1 and DPB1 susceptibility alleles in Cameroonian type 1 diabetes patients and controls.
Mbanya JC; Sobngwi E; Mbanya DN
Eur J Immunogenet; 2001 Aug; 28(4):459-62. PubMed ID: 11532022
[TBL] [Abstract][Full Text] [Related]
34. Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel.
Benedek G; Paperna T; Avidan N; Lejbkowicz I; Oksenberg JR; Wang J; Brautbar C; Israel S; Miller A;
Genes Immun; 2010 Jul; 11(5):423-31. PubMed ID: 20463743
[TBL] [Abstract][Full Text] [Related]
35. The rare HLA-DQA1*03-DQB1*02 haplotype confers susceptibility to type 1 diabetes in whites and is preferentially associated with early clinical disease onset in male subjects.
van Autreve JE; Weets I; Gulbis B; Vertongen F; Gorus FK; van der Auwera BJ;
Hum Immunol; 2004 Jul; 65(7):729-36. PubMed ID: 15301863
[TBL] [Abstract][Full Text] [Related]
36. Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score.
Onengut-Gumuscu S; Chen WM; Robertson CC; Bonnie JK; Farber E; Zhu Z; Oksenberg JR; Brant SR; Bridges SL; Edberg JC; Kimberly RP; Gregersen PK; Rewers MJ; Steck AK; Black MH; Dabelea D; Pihoker C; Atkinson MA; Wagenknecht LE; Divers J; Bell RA; ; ; Erlich HA; Concannon P; Rich SS
Diabetes Care; 2019 Mar; 42(3):406-415. PubMed ID: 30659077
[TBL] [Abstract][Full Text] [Related]
37. HLA-DRB1 and -DQB1 alleles in the Brazilian population of the northeastern region of the state of São Paulo.
Louzada-Junior P; Smith AG; Hansen JA; Donadi EA
Tissue Antigens; 2001 Feb; 57(2):158-62. PubMed ID: 11260512
[TBL] [Abstract][Full Text] [Related]
38. Association of HLA DRB1-DQB1 Haplotypes with the Risk for Neuromyelitis Optica among South Indians.
Kanikannan MA; Kathgave R; Yareeda S; Katkam SK; Kumaraswamy K; Kutala VK
Neurol India; 2022; 70(4):1481-1486. PubMed ID: 36076647
[TBL] [Abstract][Full Text] [Related]
39. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population.
Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
Eur J Neurol; 2011 Feb; 18(2):337-342. PubMed ID: 20629714
[TBL] [Abstract][Full Text] [Related]
40. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study.
Laaksonen M; Pastinen T; Sjöroos M; Kuokkanen S; Ruutiainen J; Sumelahti ML; Reijonen H; Salonen R; Wikström J; Panelius M; Partanen J; Tienari PJ; Ilonen J
J Neuroimmunol; 2002 Jan; 122(1-2):140-5. PubMed ID: 11777553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
